CRISPR

We have a dedicated CRISPR group that has amassed extensive knowledge, enabling us to stay at the cutting edge of this groundbreaking field.

CRISPR Intellectual Property Protection

Gene-editing technologies such as zinc fingers, TALENs, and CRISPR, along with their applications in areas such as diagnostics and therapeutics, have been a prominent topic in recent years. Murgitroyd’s CRISPR group has acquired extensive knowledge through their involvement with the manipulation of CRISPR systems for food applications since 2007, evolving alongside the technology itself and expanding into various other applications.

Having been at the forefront of this emerging technology, Murgitroyd is adept at guiding clients through the intricate patent landscape, offering proactive and pragmatic commercial advice. We possess a deep understanding of how patent offices are approaching this technology and the type of data required to establish robust patent protection, depending on the application of the technology within the invention.

Two women sitting at a table, smiling and working on a laptop in a bright, modern office space with notebooks, coffee, and supplies.

Talk to us

info@murgitroyd.com+1 (919) 474 8300Inquire nowMeet the team
Close-up of foam and bubbles on a liquid surface illuminated with colorful, pink and blue hues.

Our CRISPR expertise

We have an in-depth understanding of the diverse applications of various classes and types of CRISPR systems and stay updated with developments in this field. Our experience encompasses not only human therapeutics but also industrial biotechnology, microbiome, AgBio, and AI.

Our expertise is well-regarded within our industry, and we are frequently consulted for commentary by IP journals such as IAM, LSIPR, and MIP, as well as scientific publications such as Nature and Science. At the request of the Chartered Institute of Patent Attorneys, we have delivered presentations to fellow UK patent attorneys on considerations for drafting in this area.

Our collaborative environment enables us to assemble a team tailored to the specific needs of our clients. Our core team includes experts in CRISPR systems, AI, plant sciences, oppositions and pharmaceuticals.

Our CRISPR IP team

Murgitroyd is well-placed to handle cross-border patent prosecution work for clients in the software, electronics, mechanical engineering, chemistry and life sciences sectors.

Legal 500

A white logo for "The Legal 500" with elegant uppercase text and decorative lines on a black background.

Related insights

Featured insight

Sequence listings and ST26 Get ready for 1 July 2022

Sequence listings and ST26 – Get ready for 1 July 2022

Read article
  1. Read article

    Reform of Regulation of Gene-Edited Organisms – An update

  2. Read article

    UK Government Consults To De-Regulate Gene Edited Organisms In England

All insights

Talk to our CRISPR specialists

Our IP team will help you safeguard your advancements in CRISPR and maximize its value.

+44 [0] 141 307 8400info@murgitroyd.com
Fields Group
Full name
Location
Consent

By submitting this form, you agree to receive relevant communications from our Business Development and Marketing teams in accordance to our Murgitroyd Privacy Policy. You can opt out at any time.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.